Clinical Trial Update: A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications [Phase 1, Phase 2]

View source ↗

Summary

A dose-escalation Phase I study is evaluating safety and preliminary activity of a multi-indication cancer therapy in acute myeloid leukemia/myelodysplastic syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Multiple Myeloma
• Myelodysplastic Syndrome

Drugs mentioned

• Celyad Oncology SA investigational therapy

Snippet

Sponsor: Celyad Oncology SA | Conditions: Acute Myeloid Leukemia/Myelodysplastic Syndrome, Multiple Myeloma (MM) | Phase 1, Phase 2 | Status: UNKNOWN